Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 161-170 of 187 for melanoma

Edit search filters
  1. Immune Predictors Of Response To Pembrolizumab Therapy In Stage IV Melanoma Patients

    Rochester, MN

  2. Establishment of a Biorepository of Baseline and Follow-up Saliva Samples Collected from Newly Diagnosed, Treatment-naïve Cancer Patients

    Jacksonville, FL

  3. A Study To Assess The Molecular Differences In Primary Malignant Melanoma And Healthy Tissue

    Scottsdale/Phoenix, AZ

  4. A Study Of Blood And Tissue Samples To Measure Immune Responses To Melanoma

    Rochester, MN

  5. A Study To Describe Patterns Of Treatment, Demographics, Clinical Characteristics, And Overall Survival In Patients With Unresectable Or Metastatic Melanoma

    Rochester, MN

  6. Mayo Clinic Cancer Center Neuro-Oncology Program Registry And Biobank For The Study Of Nervous System Tumors

    Rochester, MN

  7. Immune Responses In Prostate, Lung, Melanoma And Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) Or Brachytherapy

    Rochester, MN

  8. A Study of the Impact of Limiting PGY-1 General Surgery Residents to 16-hour Shifts with a Mandatory 8 Hours Between Shifts on Quality of Life, Health, Education, Hours Worked and Operations Performed.

    Scottsdale/Phoenix, AZ

  9. A Study To Evaluate Maximizing Anti-PD-1 Therapy By Monitoring T Cell Responses In Melanoma, Lung And Other Cancer Types

    Jacksonville, FL, Rochester, MN

  10. The Circulating Cell-free Genome Atlas Study

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer